Discover
TLX
Telix Pharmaceuticals Limited
12.59
1 x 12.53
1 x 12.70
bid
ask
+
0.08
0.68%
1 @ 07:30 PM
12.70 +0.11 (0.87%)
| Ytd | 68.09% | |
| 1y | 37.45% |
12.55
day range
12.80
6.41
52 week range
12.83
| Open | 12.73 | Prev Close | 12.51 | Low | 12.55 | High | 12.80 | Mkt Cap | 4.27B |
| Vol | 187.40K | Avg Vol | 195.30K | EPS | 0.10 | P/E | 125.90 | Forward P/E | 346.60 |
| Beta | 0.60 | Short Ratio | 2.10 | Inst. Own | 0.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 11.26 | 200-d Avg | 9.55 | 1yr Est | 19.92 |
| Income Statement | |||
| Weighted Average Shares | 338.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 251.91M | ||
| Cash and Equivalents (USD) | 174.15M | ||
| Investments | 40.41M | ||
| Investments Non-Current | 40.41M | ||
| Trade and Non-Trade Receivables | 163.56M | ||
| Current Assets | 488.02M | ||
| Property, Plant & Equipment Net | 129.63M | ||
| Total Assets | 1.36B | ||
| Debt Current | 15.42M | ||
| Total Debt | 579.86M | ||
| Current Liabilities | 242.34M | ||
| Debt Non-Current | 564.44M | ||
| Total Liabilities | 874.18M | ||
| Accumulated Retained Earnings (Deficit) | -110.90M | ||
| Shareholders Equity | 487.68M | ||
| Shareholders Equity (USD) | 337.13M | ||
| Assets Non-Current | 873.83M | ||
| Total Debt (USD) | 400.86M | ||
| Deferred Revenue | 390.00K | ||
| Goodwill and Intangible Assets | 584.61M | ||
| Inventory | 39.03M | ||
| Liabilities Non-Current | 631.83M | ||
| Trade and Non-Trade Payables | 168.97M | ||
| Tax Assets | 92.13M | ||
| Tax Liabilities | 77.15M | ||